Skip to main content
EJNMMI Research

Table 2 Spearman’s correlations between follow-up PET-derived and MRI/RHC-derived parameters

From: The impact of specific pulmonary arterial hypertension therapy on cardiac fluorodeoxyglucose distribution in PET/MRI hybrid imaging–follow-up study

Correlation coefficient (r); p-value

SUVRV/SUVLV

6MWT

r = − 0.49; p = 0.02

BNP

r = 0.58; p = 0.007*

RV thickness

r = 0.41; p = 0.04*

RVEF

r = − 0.60; p = 0.004*

mPAP

r = 0.79; p = 0.00002*

PVR

r = 0.82; p = 0.000008*

PAC

r = − 0.73; p = 0.0003*

RVSWI

r = 0.77; p = 0.0001*

  1. * p-value significant (< 0.05) after Benjamini–Hochberg correction
  2. BNP B-type natriuretic peptide, FU Follow-up, LV Left ventricle, MRI Magnetic resonance imaging, mPAP Mean pulmonary arterial hypertension, 6MWT 6 min walk test distance, PAC Pulmonary arterial compliance, PET Positron emission tomography, PVR Pulmonary vascular resistance, RHC Right heart catheterization, RV Right ventricle, RVEF Right ventricle ejection fraction, RVSWI Right ventricle stroke work index, SUV Standardized uptake value
Back to article page